,i #aaeth ,,congress #b;d ,session ,h4 ,r4 #eggi ,,in ,,the ,,house ,,of ,,representatives ,may #aa1 #bjah,mr4 ,paulsen 7for himself and ,mr4 ,danny ,k4 ,davis of ,illinois7 introduced the following bill2 which was referred to the ,committee on ,ways and ,means1 and in addition to the ,committee on ,energy and ,commerce1 for a period to be subsequently determined by the ,speaker1 in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned ,a ,,bill ,to amend title ,,xviii of the ,social ,security ,act to require the ,secretary to establish a technical expert panel for purposes of evaluating the use of opioid-related quality measures under the ,medicare program4 #a4 ,short title ,this ,act may be cited as the ,promoting ,quality of ,care in ,pain ,management ,act of #bjah4 #b4 ,requiring the review of quality measures relating to opioids and opioid use disorder treatments furnished under the ,medicare program and other ,federal health care programs 7a7 ,in general ,section #ahij;,a of the ,social ,security ,act 7#db ,u4,s4,c4 #acie;aaa-#a7 is amended by adding at the end the following new subsection3 7g7 ,technical expert panel review of opioid and opioid use disorder quality measures 7#a7 ,in general ,not later than #ahj days after the date of the enactment of this subsection1 the ,secretary shall establish a technical expert panel for purposes of reviewing quality measures relating to opioids and opioid use disorders1 including care1 prevention1 diagnosis1 health outcomes1 and treatment furnished to individuals with opioid use disorders4 ,the ,secretary may elect to establish such panel through a contract with the consensus-based entity with a contract in effect under section #ahij4 7#b7 ,review and assessment ,not later than #a year after the date the technical expert panel described in paragraph 7#a7 is established 7and periodically thereafter as the ,secretary determines appropriate71 the technical expert panel shall-- 7,a7 review quality measures that relate to opioids and opioid use disorders1 including existing measures and those under development2 7,b7 identify gaps in areas of quality measurement that relate to opioids and opioid use disorders1 and identify measure development priorities for such measure gaps2 and 7,c7 make recommendations to the ,secretary on quality measures with respect to opioids and opioid use disorders for purposes of improving care1 prevention1 diagnosis1 health outcomes1 and treatment1 including recommendations for revisions of such measures1 need for development of new measures1 and recommendations for including such measures in quality reporting programs1 value-based purchasing programs1 accountable care organizations1 and alternative payment models under this title4 7#c7 ,consideration of measures by secretary ,the ,secretary shall consider-- 7,a7 using opioid and opioid use disorder measures 7including measures used under the ,merit-,based ,incentive ,payment ,system under section #ahdh7q71 measures recommended under paragraph 7#b77;,c71 and other such measures identified by the ,secretary7 in ,alternative ,payment ,models under section #ahcc7z77#c77;,c7 and in the ,shared ,savings ,program under section #ahii2 and 7,b7 using opioid measures described in subparagraph 7,a71 as applicable1 in the ,hospital ,inpatient ,quality ,reporting program under section #ahhf7;b77#c77;,b77viii71 in the hospital value-based purchasing program under section #ahhf7o71 and under other value-based purchasing programs under this title4 7#d7 ,prioritization of measure development ,the ,secretary shall prioritize for measure development the gaps in quality measures identified under paragraph 7#b77;,c74 4 7b7 ,expedited endorsement process for opioid measures ,section #ahij7;b77#b7 of the ,social ,security ,act 7#db ,u4,s4,c4 #acie;aaa7b77#b77 is amended by adding at the end the following new flush sentence3 ,such endorsement process shall1 as determined practicable by the entity1 provide for an expedited process with respect to the endorsement of measures relating to opioids and opioid use disorders4 4